Symbotic Inc vs 22nd Century Group Inc — how do they compare? Symbotic Inc trades at $41.19 (market cap $5.41B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Symbotic Inc is far larger — about 3559.2× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| SYM | XXII | |
|---|---|---|
Market Cap | $5.41B | $1.52M |
Sector | Technology | Technology |
52-Week High | $87.30 | $801.00 |
52-Week Low | $38.57 | $3.72 |
Enterprise Value | $3.67B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
SYM trades at $41.19, up 2.69% with bearish technical signals despite recent earnings misses. The company shows revenue growth potential with 2026 projections of $2.6B revenue and positive net income, but current profitability remains weak with negative EBITDA and slim 0.31% net margin. Recent Q3 2026 earnings missed expectations despite 21.7% revenue growth, causing a 10.3% stock drop according to Defense World on August 7, 2026.
Analyst consensus remains bullish with a $60 price target (61.11% buy ratings), but execution risks persist amid margin pressure and competitive threats. The stock faces near-term headwinds from consecutive earnings misses while long-term robotics automation trends provide growth catalysts. Current valuation metrics show elevated P/E of 1,042.25 and EV/EBITDA of 73.09, requiring significant earnings acceleration to justify.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →